Stage-agnostic early-stage VC since 2007: $165M (2019, 2 funds), $255M (2021), $550M (2025) across consumer, fintech, healthcare, enterprise, marketplaces, climate, synthetic biology
No detailed funding rounds available.
Total known funding: